Skip to Main Content

Paper Details

Knowledge of biosimilars and perceptions of the naming conventions for biosimilar products in clinical practice in the United States.
Drugs Ther Perspect
2
2021
Author NameAffiliation
Vincent Lo RePerelman School of Medicine, University of Pennsylvania
  • 1 - 1

Datasets

Release 1.2